Kellett George L, Brot-Laroche Edith
The University of York, Department of Biology, York YO10 5YW, UK.
Diabetes. 2005 Oct;54(10):3056-62. doi: 10.2337/diabetes.54.10.3056.
Understanding the mechanisms that determine postprandial fluctuations in blood glucose concentration is central for effective glycemic control in the management of diabetes. Intestinal sugar absorption is one such mechanism, and studies on its increase in experimental diabetes led us to propose a new model of sugar absorption. In the apical GLUT2 model, the glucose transported by the Na(+)/glucose cotransporter SGLT1 promotes insertion of GLUT2 into the apical membrane within minutes, so that the mechanism operates during assimilation of a meal containing high-glycemic index carbohydrate to provide a facilitated component of absorption up to three times greater than by SGLT1. Here we review the evidence for the apical GLUT2 model and describe how apical GLUT2 is a target for multiple short-term nutrient-sensing mechanisms by dietary sugars, local and endocrine hormones, cellular energy status, stress, and diabetes. These mechanisms suggest that apical GLUT2 is a potential therapeutic target for novel dietary or pharmacological approaches to control intestinal sugar delivery and thereby improve glycemic control.
了解决定餐后血糖浓度波动的机制是糖尿病管理中有效控制血糖的核心。肠道糖吸收就是这样一种机制,对实验性糖尿病中其增加的研究促使我们提出了一种新的糖吸收模型。在顶端GLUT2模型中,由钠/葡萄糖协同转运蛋白SGLT1转运的葡萄糖在数分钟内促进GLUT2插入顶端膜,因此该机制在同化含高血糖指数碳水化合物的餐食期间发挥作用,以提供比SGLT1促进吸收成分大三倍的吸收。在此,我们综述顶端GLUT2模型的证据,并描述顶端GLUT2如何成为膳食糖、局部和内分泌激素、细胞能量状态、应激及糖尿病等多种短期营养感应机制的靶点。这些机制表明,顶端GLUT2是新型饮食或药物方法控制肠道糖输送从而改善血糖控制的潜在治疗靶点。